Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KY1005-2D10 in a human skin transplant model of psoriasis
NL-OMON42911Active, not recruiting
- Sponsor
- Derphartox
- Start
- Sep 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Single-arm trial of amlitelimab in psoriasis, sponsored by Derphartox. Started Sep 2016; status: active, not recruiting.
02
Drugs
amlitelimab
03
Conditions
psoriasis
Beyond the preview
Go deeper on NL-OMON42911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42911.